74
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Fluvastatin and fluvastatin extended release: a clinical and safety profile

&
Pages 641-652 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

MT Bennett, KW Johns & GP Bondy. (2008) Current and future treatments of HIV-associated dyslipidemia. Future Lipidology 3:2, pages 175-188.
Read now
Mark Y Chan & Chi Hang Lee. (2005) Fluvastatin: efficacy and safety in reducing cardiac events. Expert Opinion on Pharmacotherapy 6:11, pages 1883-1895.
Read now
Evagelos N. Liberopoulos, Stella S. Daskalopoulou, Dimitri P. Mikhailidis, Anthony S. Wierzbicki & Moses S. Elisaf. (2005) A review of the lipid-related effects of fluvastatin. Current Medical Research and Opinion 21:2, pages 231-243.
Read now

Articles from other publishers (10)

Dong-Kun Li, Jing-Yi Tan, Wei Deng & Zheng-Yang Xu. (2021) Reduction of bis(5-alkyl-2-furyl)(2-nitroaryl)methane with aqueous titanium trichloride solution. Tetrahedron 99, pages 132407.
Crossref
Donald J. AbrahamScott D. Edmondson, Duane A. Burnett & Harry R. DavisJrJr. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 36 .
Guo-Bo Deng, Jia-Ling Zhang, Yan-Yun Liu, Bang Liu, Xu-Heng Yang & Jin-Heng Li. (2015) Metal-free nitrative cyclization of N-aryl imines with tert-butyl nitrite: dehydrogenative access to 3-nitroindoles. Chemical Communications 51:10, pages 1886-1888.
Crossref
Vladimir T. Abaev, Anastasiya T. Plieva, Petrakis N. Chalikidi, Maxim G. Uchuskin, Igor V. Trushkov & Alexander V. Butin. (2014) A Simple Route to Polysubstituted Indoles Exploiting Azide Induced Furan Ring Opening. Organic Letters 16:16, pages 4150-4153.
Crossref
Helena Buzkova, Kristina Pechandova, Vilem Danzig, Tomas Vareka, Frantisek Perlik, Ales Zak & Ondrej Slanar. (2012) Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population. Medical Science Monitor 18:8, pages CR512-CR517.
Crossref
Sven Stegemann, Imre Klebovich, István Antal, Henning H. Blume, Kálmán Magyar, György Németh, Tamás L. Paál, Willibald Stumptner, György Thaler, Armand Van de Putte & Vinod P. Shah. (2011) Improved therapeutic entities derived from known generics as an unexplored source of innovative drug products. European Journal of Pharmaceutical Sciences 44:4, pages 447-454.
Crossref
Kosmas I. Paraskevas, Dimitri P. Mikhailidis & Frank J. Veith. (2011) Optimal statin type and dosage for vascular patients. Journal of Vascular Surgery 53:3, pages 837-844.
Crossref
Donald J. AbrahamDuane A. Burnett & Harry R. DavisJr.Jr.. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 303 330 .
Min-Yu Hu, Yi-Lin Li, Chong-He Jiang, Zhao-Qian Liu, Shu-Lin Qu & Yi-Ming Huang. (2008) Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition 24:10, pages 1030-1038.
Crossref
Tomasz Grabarkiewicz, Pawel Grobelny, Marcin Hoffmann & Jadwiga Mielcarek. (2006) DFT study on hydroxy acid–lactone interconversion of statins: the case of fluvastatin. Org. Biomol. Chem. 4:23, pages 4299-4306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.